Contact Us
Nanotechnology In Cancer Treatment Global Market Report 2025
Global Nanotechnology In Cancer Treatment Market Report 2025
Item added to cart!

Published : December 2025

Pages : 250

Format : PDF

Delivery Time : 2-3 Business Days

Report Price : $4490.00 $3367.00

Purchase This Report Download Sample PDF
Purchase This Report

Nanotechnology In Cancer Treatment Global Market Report 2025

By Nanotechnology Type (Liposomes, Dendrimers, Nanoparticles), By Treatment Type (Chemotherapy, Immunotherapy, Targeted Therapy, Combined Therapy Approaches, Surgery Assistance), By Cancer Type (Breast Cancer, Lung Cancer, Prostate Cancer, Colorectal Cancer, Blood Cancer, Other Cancer Types), By Application (Targeted Drug Delivery, Photothermal Therapy, Radiation Therapy Enhancement, Diagnostics And Imaging, Gene Delivery Systems), By End-User (Hospitals, Research Institutions, Diagnostics Laboratories, Pharmaceutical Companies, Contract Research Organizations (CROs)) - Market Size, Trends, And Global Forecast 2025-2034

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

Nanotechnology In Cancer Treatment Market Overview

• Nanotechnology In Cancer Treatment market size has reached to $137.90 billion in 2024

• Expected to grow to $278.07 billion in 2029 at a compound annual growth rate (CAGR) of 15%

• Growth Driver: Rising Demand For Targeted Therapies Drives Growth In Nanotechnology-Based Cancer Treatment Due To Their Precision In Attacking Cancer Cells

• Market Trend: Breakthrough In Nanotechnology-Enabled Immunotherapy For Precision Cancer Treatment

North America was the largest region in 2024 and Asia-Pacific is the fastest growing region.

What Is Covered Under Nanotechnology In Cancer Treatment Market?

Nanotechnology in cancer treatment involves utilizing nanoscale materials and tools to enhance cancer diagnosis, monitoring, and therapy. It allows for precise drug delivery to cancer cells, reducing harm to surrounding healthy tissues. This approach aims to boost treatment effectiveness, lower side effects, and support personalized medicine strategies.

The main types of nanotechnology in cancer treatment are liposomes, dendrimers, and nanoparticles. Liposomes refer to tiny spherical vesicles made from lipid bilayers used to deliver drugs directly to targeted cells in the body. The treatment types include chemotherapy, immunotherapy, targeted therapy, combined therapy approaches, and surgery assistance and are used for various cancer types, such as breast cancer, lung cancer, prostate cancer, colorectal cancer, blood cancer, and others. These are used in several applications, including targeted drug delivery, photothermal therapy, radiation therapy enhancement, diagnostics and imaging, and gene delivery systems, and also by various end-users such as hospitals, research institutions, diagnostic laboratories, pharmaceutical companies, and contract research organizations (CROs).

Nanotechnology In Cancer Treatment Market Size and growth rate 2025 to 2029: Graph

What Is The Nanotechnology In Cancer Treatment Market Size 2025 And Growth Rate?

The nanotechnology in the cancer treatment market size has grown rapidly in recent years. It will grow from $137.90 billion in 2024 to $159.09 billion in 2025 at a compound annual growth rate (CAGR) of 15.4%. The growth in the historic period can be attributed to the early rising prevalence of cancer globally, increasing awareness of early cancer detection, increasing research and development investments in nanomedicine, rising adoption of minimally invasive treatments, and increasing government funding for oncology nanotech research.

What Is The Nanotechnology In Cancer Treatment Market Growth Forecast?

The nanotechnology in the cancer treatment market size is expected to see rapid growth in the next few years. It will grow to $278.07 billion in 2029 at a compound annual growth rate (CAGR) of 15.0%. The growth in the forecast period can be attributed to rising demand for targeted cancer therapies, increasing integration of nanotechnology in drug delivery systems, growing focus on personalized oncology treatment, increasing clinical trials for nano-enabled cancer drugs, and rising adoption of nanotheranostics in cancer care. Major trends in the forecast period include advancement in nanoparticle drug delivery platforms, innovation in cancer-specific nanocarriers, integration of AI with nanotechnology for precision oncology, development of multifunctional nanodevices for diagnosis and therapy, and expansion of nanotheranostics in personalized medicine.

Customer representative image Book your 30 minutes free consultation with our research experts

What’s The Trade War Impact On Healthcare Services Industry?

The sudden escalation of U.S. tariffs and the consequent trade frictions in spring 2025 are severely impacting the healthcare sector, particularly in the supply of critical medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are facing higher costs for imported surgical instruments, imaging equipment, and consumables such as syringes and catheters, many of which have limited domestic alternatives. These increased costs are straining healthcare budgets, leading some providers to delay equipment upgrades or pass on expenses to patients. Additionally, tariffs on raw materials and components are disrupting the production of essential drugs and devices, causing supply chain bottlenecks. In response, the industry is diversifying sourcing strategies, boosting local manufacturing where possible, and advocating for tariff exemptions on life-saving medical products.

How Is The Nanotechnology In Cancer Treatment Market Segmented?

1) By Nanotechnology Type: Liposomes, Dendrimers, Nanoparticles

2) By Treatment Type: Chemotherapy, Immunotherapy, Targeted Therapy, Combined Therapy Approaches, Surgery Assistance

3) By Cancer Type: Breast Cancer, Lung Cancer, Prostate Cancer, Colorectal Cancer, Blood Cancer, Other Cancer Types

4) By Application: Targeted Drug Delivery, Photothermal Therapy, Radiation Therapy Enhancement, Diagnostics And Imaging, Gene Delivery Systems

5) By End-User: Hospitals, Research Institutions, Diagnostics Laboratories, Pharmaceutical Companies, Contract Research Organizations (CROs)

Subsegments:

1) By Liposomes: Conventional Liposomes, Stealth Liposomes, Cationic Liposomes, Immunoliposomes

2) By Dendrimers: Polyamidoamine Dendrimers, Polypropyleneimine Dendrimers, Peptide-Based Dendrimers, Carbosilane Dendrimers

3) By Nanoparticles: Gold Nanoparticles, Magnetic Nanoparticles, Polymeric Nanoparticles, quantum dots, Lipid Nanoparticles

What Is Driving The Nanotechnology In Cancer Treatment Market? Rising Demand For Targeted Therapies Drives Growth In Nanotechnology-Based Cancer Treatment Due To Their Precision In Attacking Cancer Cells

The growing demand for targeted therapies is expected to propel the growth of nanotechnology in the cancer treatment market going forward. Targeted therapies refer to cancer treatments that specifically target molecular markers or pathways involved in tumor growth and progression. The rise in demand for targeted therapies is due to their ability to precisely attack cancer cells, reducing damage to healthy tissue and minimizing side effects. Nanotechnology in cancer treatment enhances targeted therapies by enabling precise delivery of drugs directly to cancer cells, improving effectiveness and minimizing harm to healthy tissues. For instance, in July 2023, according to the report published by the American Society of Gene & Cell Therapy (ASGCT), a US-based professional membership organization, at the end of Q1 2023, there were 247 gene therapies in Phase II, this number rose by 5% and reached 260 by the end of Q2 2023. Therefore, the growing demand for targeted therapies is driving the growth of nanotechnology in the cancer treatment market.

Who Are The Major Players In The Global Nanotechnology In Cancer Treatment Market?

Major companies operating in the nanotechnology in cancer treatment market are Pfizer Inc., AstraZeneca PLC, Novartis AG, Amgen Inc., GE Healthcare Technologies Inc., Eisai Co. Ltd., Jazz Pharmaceuticals plc, Arrowhead Pharmaceuticals Inc., Nanobiotix S.A., EnGeneIC Ltd., Nanospectra Biosciences Inc., Sona Nanotech Inc., CritiTech Inc., Immix Biopharma Inc., DNA Nanobots LLC, Nanovery Limited, CytImmune Sciences Inc., NanOlogy LLC, NanoApps Medical Inc., ARIZ Precision Medicine.

What Are The Key Trends Of The Global Nanotechnology In Cancer Treatment Market? Breakthrough In Nanotechnology-Enabled Immunotherapy For Precision Cancer Treatment

Major companies operating in the nanotechnology in cancer treatment market are focusing on developing advanced treatments such as immunotherapy nano formulation to enhance immune system targeting and minimize adverse effects in cancer patients. Immunotherapy nano formulation uses nanotechnology to deliver immune-based therapies directly to target sites, enhancing precision treatment while improving drug stability, bioavailability, and immune response activation. For instance, in December 2023, Cello Therapeutics, a US-based biotechnology company, launched CE120, a broad-spectrum therapeutic cancer nano vaccine that secured Food and Drug Administration clearance. This therapy marks the first clinical use of platelet membrane-coated nanoparticles for treating solid tumors. CE120 combines targeted drug delivery with immune system activation, aiming to destroy tumors and prevent recurrence. Its unique nanotechnology platform enhances both therapeutic precision and immune response. This milestone positions CE120 as a pioneering nanomedicine in cancer treatment.

Need data on a specific region in this market?

What Are Latest Mergers And Acquisitions In The Nanotechnology In Cancer Treatment Market? Sona Nanotech Acquired Siva Therapeutics To Advance Gold Nanorod-Based Cancer Therapies

In March 2023, Sona Nanotech Inc., a Canada-based company that offers nanotechnology in cancer treatments, acquired Siva Therapeutics for $2.0 million. With this acquisition, Sona Nanotech aims to expand into cancer therapeutics by developing gold nanorod-based targeted hyperthermia treatments for solid tumors, supporting Sona’s goal of advancing nanotech-based cancer treatments. Siva Therapeutics Inc. is a US-based company that develops nanotechnology-based cancer treatments, specifically through its targeted hyperthermia therapy (THT) platform.

What Is The Regional Outlook For The Global Nanotechnology In Cancer Treatment Market?

North America was the largest region in the nanotechnology in cancer treatment market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Nanotechnology In Cancer Treatment Market?

The nanotechnology in cancer treatment market consists of revenues earned by entities by providing services such as hyperthermia therapy services, multi-drug co-delivery services, and immune checkpoint modulation services. The market value includes the value of related goods sold by the service provider or included within the service offering. The nanotechnology in cancer treatment market also includes sales of magnetic nanoparticles, carbon nanotubes, polymeric nanoparticles, and quantum dots. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What is the Market Assessment and Strategic Outlook for the Nanotechnology In Cancer Treatment Industry?

The nanotechnology in cancer treatment market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the nanotechnology in cancer treatment industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.

Author : Abdul Wasay

Nanotechnology In Cancer Treatment Market Report Forecast Analysis

Report AttributeDetails
Market Size Value In 2025 $159.09 billion
Revenue Forecast In 2034 $278.07 billion
Growth Rate CAGR of 15.0% from 2025 to 2034
Base Year For Estimation 2024
Actual Estimates/Historical Data 2019-2024
Forecast Period 2025 - 2029 - 2034
Market Representation Revenue in USD Billion and CAGR from 2025 to 2034
Segments Covered Nanotechnology Type, Treatment Type, Cancer Type, Application, End-User
Regional Scope Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope The countries covered in the report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain. Additional countries that can be covered in the report are Bangladesh, Thailand, Vietnam, Malaysia, Singapore, Philippines, Hong Kong, New Zealand, Mexico, Chile, Argentina, Colombia, Peru, Austria, Belgium, Denmark, Finland, Ireland, Netherlands, Norway, Portugal, Sweden, Switzerland, Czech Republic, Poland, Romania, Ukraine, Saudi Arabia, Israel, Iran, Turkey, UAE, Egypt, Nigeria, South Africa.
Key Companies Profiled Pfizer Inc., AstraZeneca PLC, Novartis AG, Amgen Inc., GE Healthcare Technologies Inc., Eisai Co. Ltd., Jazz Pharmaceuticals plc, Arrowhead Pharmaceuticals Inc., Nanobiotix S.A., EnGeneIC Ltd., Nanospectra Biosciences Inc., Sona Nanotech Inc., CritiTech Inc., Immix Biopharma Inc., DNA Nanobots LLC, Nanovery Limited, CytImmune Sciences Inc., NanOlogy LLC, NanoApps Medical Inc., ARIZ Precision Medicine.
Customization ScopeRequest for Sample
Pricing And Purchase OptionsExplore Purchase Options

Table Of Contents

1. Executive Summary

2. Nanotechnology In Cancer Treatment Market Characteristics

3. Nanotechnology In Cancer Treatment Market Trends And Strategies

4. Nanotechnology In Cancer Treatment Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Nanotechnology In Cancer Treatment Growth Analysis And Strategic Analysis Framework

5.1. Global Nanotechnology In Cancer Treatment PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

5.2. Analysis Of End Use Industries

5.3. Global Nanotechnology In Cancer Treatment Market Growth Rate Analysis

5.4. Global Nanotechnology In Cancer Treatment Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)

5.5. Global Nanotechnology In Cancer Treatment Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)

5.6. Global Nanotechnology In Cancer Treatment Total Addressable Market (TAM)

6. Nanotechnology In Cancer Treatment Market Segmentation

6.1. Global Nanotechnology In Cancer Treatment Market, Segmentation By Nanotechnology Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Liposomes

Dendrimers

Nanoparticles

6.2. Global Nanotechnology In Cancer Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Chemotherapy

Immunotherapy

Targeted Therapy

Combined Therapy Approaches

Surgery Assistance

6.3. Global Nanotechnology In Cancer Treatment Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Breast Cancer

Lung Cancer

Prostate Cancer

Colorectal Cancer

Blood Cancer

Other Cancer Types

6.4. Global Nanotechnology In Cancer Treatment Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Targeted Drug Delivery

Photothermal Therapy

Radiation Therapy Enhancement

Diagnostics And Imaging

Gene Delivery Systems

6.5. Global Nanotechnology In Cancer Treatment Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Research Institutions

Diagnostics Laboratories

Pharmaceutical Companies

Contract Research Organizations (CROs)

6.6. Global Nanotechnology In Cancer Treatment Market, Sub-Segmentation Of Liposomes, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Conventional Liposomes

Stealth Liposomes

Cationic Liposomes

Immunoliposomes

6.7. Global Nanotechnology In Cancer Treatment Market, Sub-Segmentation Of Dendrimers, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Polyamidoamine Dendrimers

Polypropyleneimine Dendrimers

Peptide-Based Dendrimers

Carbosilane Dendrimers

6.8. Global Nanotechnology In Cancer Treatment Market, Sub-Segmentation Of Nanoparticles, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Gold Nanoparticles

Magnetic Nanoparticles

Polymeric Nanoparticles

Quantum Dots

Lipid Nanoparticles

7. Nanotechnology In Cancer Treatment Market Regional And Country Analysis

7.1. Global Nanotechnology In Cancer Treatment Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

7.2. Global Nanotechnology In Cancer Treatment Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Nanotechnology In Cancer Treatment Market

8.1. Asia-Pacific Nanotechnology In Cancer Treatment Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

8.2. Asia-Pacific Nanotechnology In Cancer Treatment Market, Segmentation By Nanotechnology Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8.3. Asia-Pacific Nanotechnology In Cancer Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8.4. Asia-Pacific Nanotechnology In Cancer Treatment Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Nanotechnology In Cancer Treatment Market

9.1. China Nanotechnology In Cancer Treatment Market Overview

9.2. China Nanotechnology In Cancer Treatment Market, Segmentation By Nanotechnology Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

9.3. China Nanotechnology In Cancer Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

9.4. China Nanotechnology In Cancer Treatment Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Nanotechnology In Cancer Treatment Market

10.1. India Nanotechnology In Cancer Treatment Market, Segmentation By Nanotechnology Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

10.2. India Nanotechnology In Cancer Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

10.3. India Nanotechnology In Cancer Treatment Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Nanotechnology In Cancer Treatment Market

11.1. Japan Nanotechnology In Cancer Treatment Market Overview

11.2. Japan Nanotechnology In Cancer Treatment Market, Segmentation By Nanotechnology Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11.3. Japan Nanotechnology In Cancer Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11.4. Japan Nanotechnology In Cancer Treatment Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Nanotechnology In Cancer Treatment Market

12.1. Australia Nanotechnology In Cancer Treatment Market, Segmentation By Nanotechnology Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12.2. Australia Nanotechnology In Cancer Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12.3. Australia Nanotechnology In Cancer Treatment Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Nanotechnology In Cancer Treatment Market

13.1. Indonesia Nanotechnology In Cancer Treatment Market, Segmentation By Nanotechnology Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13.2. Indonesia Nanotechnology In Cancer Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13.3. Indonesia Nanotechnology In Cancer Treatment Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Nanotechnology In Cancer Treatment Market

14.1. South Korea Nanotechnology In Cancer Treatment Market Overview

14.2. South Korea Nanotechnology In Cancer Treatment Market, Segmentation By Nanotechnology Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14.3. South Korea Nanotechnology In Cancer Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14.4. South Korea Nanotechnology In Cancer Treatment Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Nanotechnology In Cancer Treatment Market

15.1. Western Europe Nanotechnology In Cancer Treatment Market Overview

15.2. Western Europe Nanotechnology In Cancer Treatment Market, Segmentation By Nanotechnology Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15.3. Western Europe Nanotechnology In Cancer Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15.4. Western Europe Nanotechnology In Cancer Treatment Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Nanotechnology In Cancer Treatment Market

16.1. UK Nanotechnology In Cancer Treatment Market, Segmentation By Nanotechnology Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16.2. UK Nanotechnology In Cancer Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16.3. UK Nanotechnology In Cancer Treatment Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Nanotechnology In Cancer Treatment Market

17.1. Germany Nanotechnology In Cancer Treatment Market, Segmentation By Nanotechnology Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17.2. Germany Nanotechnology In Cancer Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17.3. Germany Nanotechnology In Cancer Treatment Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Nanotechnology In Cancer Treatment Market

18.1. France Nanotechnology In Cancer Treatment Market, Segmentation By Nanotechnology Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18.2. France Nanotechnology In Cancer Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18.3. France Nanotechnology In Cancer Treatment Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Nanotechnology In Cancer Treatment Market

19.1. Italy Nanotechnology In Cancer Treatment Market, Segmentation By Nanotechnology Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19.2. Italy Nanotechnology In Cancer Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19.3. Italy Nanotechnology In Cancer Treatment Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Nanotechnology In Cancer Treatment Market

20.1. Spain Nanotechnology In Cancer Treatment Market, Segmentation By Nanotechnology Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20.2. Spain Nanotechnology In Cancer Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20.3. Spain Nanotechnology In Cancer Treatment Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Nanotechnology In Cancer Treatment Market

21.1. Eastern Europe Nanotechnology In Cancer Treatment Market Overview

21.2. Eastern Europe Nanotechnology In Cancer Treatment Market, Segmentation By Nanotechnology Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21.3. Eastern Europe Nanotechnology In Cancer Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21.4. Eastern Europe Nanotechnology In Cancer Treatment Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Nanotechnology In Cancer Treatment Market

22.1. Russia Nanotechnology In Cancer Treatment Market, Segmentation By Nanotechnology Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22.2. Russia Nanotechnology In Cancer Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22.3. Russia Nanotechnology In Cancer Treatment Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Nanotechnology In Cancer Treatment Market

23.1. North America Nanotechnology In Cancer Treatment Market Overview

23.2. North America Nanotechnology In Cancer Treatment Market, Segmentation By Nanotechnology Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23.3. North America Nanotechnology In Cancer Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23.4. North America Nanotechnology In Cancer Treatment Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Nanotechnology In Cancer Treatment Market

24.1. USA Nanotechnology In Cancer Treatment Market Overview

24.2. USA Nanotechnology In Cancer Treatment Market, Segmentation By Nanotechnology Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24.3. USA Nanotechnology In Cancer Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24.4. USA Nanotechnology In Cancer Treatment Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Nanotechnology In Cancer Treatment Market

25.1. Canada Nanotechnology In Cancer Treatment Market Overview

25.2. Canada Nanotechnology In Cancer Treatment Market, Segmentation By Nanotechnology Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25.3. Canada Nanotechnology In Cancer Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25.4. Canada Nanotechnology In Cancer Treatment Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Nanotechnology In Cancer Treatment Market

26.1. South America Nanotechnology In Cancer Treatment Market Overview

26.2. South America Nanotechnology In Cancer Treatment Market, Segmentation By Nanotechnology Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26.3. South America Nanotechnology In Cancer Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26.4. South America Nanotechnology In Cancer Treatment Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Nanotechnology In Cancer Treatment Market

27.1. Brazil Nanotechnology In Cancer Treatment Market, Segmentation By Nanotechnology Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27.2. Brazil Nanotechnology In Cancer Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27.3. Brazil Nanotechnology In Cancer Treatment Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Nanotechnology In Cancer Treatment Market

28.1. Middle East Nanotechnology In Cancer Treatment Market Overview

28.2. Middle East Nanotechnology In Cancer Treatment Market, Segmentation By Nanotechnology Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28.3. Middle East Nanotechnology In Cancer Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28.4. Middle East Nanotechnology In Cancer Treatment Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Nanotechnology In Cancer Treatment Market

29.1. Africa Nanotechnology In Cancer Treatment Market Overview

29.2. Africa Nanotechnology In Cancer Treatment Market, Segmentation By Nanotechnology Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29.3. Africa Nanotechnology In Cancer Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29.4. Africa Nanotechnology In Cancer Treatment Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Nanotechnology In Cancer Treatment Market Competitive Landscape And Company Profiles

30.1. Nanotechnology In Cancer Treatment Market Competitive Landscape

30.2. Nanotechnology In Cancer Treatment Market Company Profiles

30.2.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis

30.2.2. AstraZeneca PLC Overview, Products and Services, Strategy and Financial Analysis

30.2.3. Novartis AG Overview, Products and Services, Strategy and Financial Analysis

30.2.4. Amgen Inc. Overview, Products and Services, Strategy and Financial Analysis

30.2.5. GE Healthcare Technologies Inc. Overview, Products and Services, Strategy and Financial Analysis

31. Nanotechnology In Cancer Treatment Market Other Major And Innovative Companies

31.1. Eisai Co. Ltd.

31.2. Jazz Pharmaceuticals plc

31.3. Arrowhead Pharmaceuticals Inc.

31.4. Nanobiotix S.A.

31.5. EnGeneIC Ltd.

31.6. Nanospectra Biosciences Inc.

31.7. Sona Nanotech Inc.

31.8. CritiTech Inc.

31.9. Immix Biopharma Inc.

31.10. DNA Nanobots LLC

31.11. Nanovery Limited

31.12. CytImmune Sciences Inc.

31.13. NanOlogy LLC

31.14. NanoApps Medical Inc.

31.15. ARIZ Precision Medicine

32. Global Nanotechnology In Cancer Treatment Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Nanotechnology In Cancer Treatment Market

34. Recent Developments In The Nanotechnology In Cancer Treatment Market

35. Nanotechnology In Cancer Treatment Market High Potential Countries, Segments and Strategies

35.1 Nanotechnology In Cancer Treatment Market In 2029 - Countries Offering Most New Opportunities

35.2 Nanotechnology In Cancer Treatment Market In 2029 - Segments Offering Most New Opportunities

35.3 Nanotechnology In Cancer Treatment Market In 2029 - Growth Strategies

35.3.1 Market Trend Based Strategies

35.3.2 Competitor Strategies

36. Appendix

36.1. Abbreviations

36.2. Currencies

36.3. Historic And Forecast Inflation Rates

36.4. Research Inquiries

36.5. The Business Research Company

36.6. Copyright And Disclaimer

List Of Tables

    Table 1: Global Historic Market Growth, 2019-2024, $ Billion
  • Table 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion
  • Table 3: Global Nanotechnology In Cancer Treatment Market, Segmentation By Nanotechnology Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 4: Global Nanotechnology In Cancer Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 5: Global Nanotechnology In Cancer Treatment Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 6: Global Nanotechnology In Cancer Treatment Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 7: Global Nanotechnology In Cancer Treatment Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 8: Global Nanotechnology In Cancer Treatment Market, Sub-Segmentation Of Liposomes, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 9: Global Nanotechnology In Cancer Treatment Market, Sub-Segmentation Of Dendrimers, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 10: Global Nanotechnology In Cancer Treatment Market, Sub-Segmentation Of Nanoparticles, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 11: Global Nanotechnology In Cancer Treatment Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 12: Global Nanotechnology In Cancer Treatment Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 13: Asia-Pacific, Nanotechnology In Cancer Treatment Market, Segmentation By Nanotechnology Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 14: Asia-Pacific, Nanotechnology In Cancer Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 15: Asia-Pacific, Nanotechnology In Cancer Treatment Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 16: China, Nanotechnology In Cancer Treatment Market, Segmentation By Nanotechnology Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 17: China, Nanotechnology In Cancer Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 18: China, Nanotechnology In Cancer Treatment Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 19: India, Nanotechnology In Cancer Treatment Market, Segmentation By Nanotechnology Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 20: India, Nanotechnology In Cancer Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 21: India, Nanotechnology In Cancer Treatment Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 22: Japan, Nanotechnology In Cancer Treatment Market, Segmentation By Nanotechnology Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 23: Japan, Nanotechnology In Cancer Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 24: Japan, Nanotechnology In Cancer Treatment Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 25: Australia, Nanotechnology In Cancer Treatment Market, Segmentation By Nanotechnology Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 26: Australia, Nanotechnology In Cancer Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 27: Australia, Nanotechnology In Cancer Treatment Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 28: Indonesia, Nanotechnology In Cancer Treatment Market, Segmentation By Nanotechnology Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 29: Indonesia, Nanotechnology In Cancer Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 30: Indonesia, Nanotechnology In Cancer Treatment Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 31: South Korea, Nanotechnology In Cancer Treatment Market, Segmentation By Nanotechnology Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 32: South Korea, Nanotechnology In Cancer Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 33: South Korea, Nanotechnology In Cancer Treatment Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 34: Western Europe, Nanotechnology In Cancer Treatment Market, Segmentation By Nanotechnology Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 35: Western Europe, Nanotechnology In Cancer Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 36: Western Europe, Nanotechnology In Cancer Treatment Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 37: UK, Nanotechnology In Cancer Treatment Market, Segmentation By Nanotechnology Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 38: UK, Nanotechnology In Cancer Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 39: UK, Nanotechnology In Cancer Treatment Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 40: Germany, Nanotechnology In Cancer Treatment Market, Segmentation By Nanotechnology Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 41: Germany, Nanotechnology In Cancer Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 42: Germany, Nanotechnology In Cancer Treatment Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 43: France, Nanotechnology In Cancer Treatment Market, Segmentation By Nanotechnology Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 44: France, Nanotechnology In Cancer Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 45: France, Nanotechnology In Cancer Treatment Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 46: Italy, Nanotechnology In Cancer Treatment Market, Segmentation By Nanotechnology Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 47: Italy, Nanotechnology In Cancer Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 48: Italy, Nanotechnology In Cancer Treatment Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 49: Spain, Nanotechnology In Cancer Treatment Market, Segmentation By Nanotechnology Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 50: Spain, Nanotechnology In Cancer Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 51: Spain, Nanotechnology In Cancer Treatment Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 52: Eastern Europe, Nanotechnology In Cancer Treatment Market, Segmentation By Nanotechnology Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 53: Eastern Europe, Nanotechnology In Cancer Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 54: Eastern Europe, Nanotechnology In Cancer Treatment Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 55: Russia, Nanotechnology In Cancer Treatment Market, Segmentation By Nanotechnology Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 56: Russia, Nanotechnology In Cancer Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 57: Russia, Nanotechnology In Cancer Treatment Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 58: North America, Nanotechnology In Cancer Treatment Market, Segmentation By Nanotechnology Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 59: North America, Nanotechnology In Cancer Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 60: North America, Nanotechnology In Cancer Treatment Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 61: USA, Nanotechnology In Cancer Treatment Market, Segmentation By Nanotechnology Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 62: USA, Nanotechnology In Cancer Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 63: USA, Nanotechnology In Cancer Treatment Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 64: Canada, Nanotechnology In Cancer Treatment Market, Segmentation By Nanotechnology Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 65: Canada, Nanotechnology In Cancer Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 66: Canada, Nanotechnology In Cancer Treatment Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 67: South America, Nanotechnology In Cancer Treatment Market, Segmentation By Nanotechnology Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 68: South America, Nanotechnology In Cancer Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 69: South America, Nanotechnology In Cancer Treatment Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 70: Brazil, Nanotechnology In Cancer Treatment Market, Segmentation By Nanotechnology Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 71: Brazil, Nanotechnology In Cancer Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 72: Brazil, Nanotechnology In Cancer Treatment Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 73: Middle East, Nanotechnology In Cancer Treatment Market, Segmentation By Nanotechnology Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 74: Middle East, Nanotechnology In Cancer Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 75: Middle East, Nanotechnology In Cancer Treatment Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 76: Africa, Nanotechnology In Cancer Treatment Market, Segmentation By Nanotechnology Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 77: Africa, Nanotechnology In Cancer Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 78: Africa, Nanotechnology In Cancer Treatment Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 79: Pfizer Inc. Financial Performance
  • Table 80: AstraZeneca PLC Financial Performance
  • Table 81: Novartis AG Financial Performance
  • Table 82: Amgen Inc. Financial Performance
  • Table 83: GE Healthcare Technologies Inc. Financial Performance

List Of Figures

    Figure 1: Global Historic Market Growth, 2019-2024, $ Billion
  • Figure 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion
  • Figure 3: Global Nanotechnology In Cancer Treatment Market, Segmentation By Nanotechnology Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 4: Global Nanotechnology In Cancer Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 5: Global Nanotechnology In Cancer Treatment Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 6: Global Nanotechnology In Cancer Treatment Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 7: Global Nanotechnology In Cancer Treatment Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 8: Global Nanotechnology In Cancer Treatment Market, Sub-Segmentation Of Liposomes, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 9: Global Nanotechnology In Cancer Treatment Market, Sub-Segmentation Of Dendrimers, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 10: Global Nanotechnology In Cancer Treatment Market, Sub-Segmentation Of Nanoparticles, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 11: Global Nanotechnology In Cancer Treatment Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 12: Global Nanotechnology In Cancer Treatment Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 13: Asia-Pacific, Nanotechnology In Cancer Treatment Market, Segmentation By Nanotechnology Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 14: Asia-Pacific, Nanotechnology In Cancer Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 15: Asia-Pacific, Nanotechnology In Cancer Treatment Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 16: China, Nanotechnology In Cancer Treatment Market, Segmentation By Nanotechnology Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 17: China, Nanotechnology In Cancer Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 18: China, Nanotechnology In Cancer Treatment Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 19: India, Nanotechnology In Cancer Treatment Market, Segmentation By Nanotechnology Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 20: India, Nanotechnology In Cancer Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 21: India, Nanotechnology In Cancer Treatment Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 22: Japan, Nanotechnology In Cancer Treatment Market, Segmentation By Nanotechnology Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 23: Japan, Nanotechnology In Cancer Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 24: Japan, Nanotechnology In Cancer Treatment Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 25: Australia, Nanotechnology In Cancer Treatment Market, Segmentation By Nanotechnology Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 26: Australia, Nanotechnology In Cancer Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 27: Australia, Nanotechnology In Cancer Treatment Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 28: Indonesia, Nanotechnology In Cancer Treatment Market, Segmentation By Nanotechnology Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 29: Indonesia, Nanotechnology In Cancer Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 30: Indonesia, Nanotechnology In Cancer Treatment Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 31: South Korea, Nanotechnology In Cancer Treatment Market, Segmentation By Nanotechnology Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 32: South Korea, Nanotechnology In Cancer Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 33: South Korea, Nanotechnology In Cancer Treatment Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 34: Western Europe, Nanotechnology In Cancer Treatment Market, Segmentation By Nanotechnology Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 35: Western Europe, Nanotechnology In Cancer Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 36: Western Europe, Nanotechnology In Cancer Treatment Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 37: UK, Nanotechnology In Cancer Treatment Market, Segmentation By Nanotechnology Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 38: UK, Nanotechnology In Cancer Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 39: UK, Nanotechnology In Cancer Treatment Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 40: Germany, Nanotechnology In Cancer Treatment Market, Segmentation By Nanotechnology Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 41: Germany, Nanotechnology In Cancer Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 42: Germany, Nanotechnology In Cancer Treatment Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 43: France, Nanotechnology In Cancer Treatment Market, Segmentation By Nanotechnology Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 44: France, Nanotechnology In Cancer Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 45: France, Nanotechnology In Cancer Treatment Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 46: Italy, Nanotechnology In Cancer Treatment Market, Segmentation By Nanotechnology Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 47: Italy, Nanotechnology In Cancer Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 48: Italy, Nanotechnology In Cancer Treatment Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 49: Spain, Nanotechnology In Cancer Treatment Market, Segmentation By Nanotechnology Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 50: Spain, Nanotechnology In Cancer Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 51: Spain, Nanotechnology In Cancer Treatment Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 52: Eastern Europe, Nanotechnology In Cancer Treatment Market, Segmentation By Nanotechnology Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 53: Eastern Europe, Nanotechnology In Cancer Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 54: Eastern Europe, Nanotechnology In Cancer Treatment Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 55: Russia, Nanotechnology In Cancer Treatment Market, Segmentation By Nanotechnology Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 56: Russia, Nanotechnology In Cancer Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 57: Russia, Nanotechnology In Cancer Treatment Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 58: North America, Nanotechnology In Cancer Treatment Market, Segmentation By Nanotechnology Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 59: North America, Nanotechnology In Cancer Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 60: North America, Nanotechnology In Cancer Treatment Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 61: USA, Nanotechnology In Cancer Treatment Market, Segmentation By Nanotechnology Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 62: USA, Nanotechnology In Cancer Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 63: USA, Nanotechnology In Cancer Treatment Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 64: Canada, Nanotechnology In Cancer Treatment Market, Segmentation By Nanotechnology Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 65: Canada, Nanotechnology In Cancer Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 66: Canada, Nanotechnology In Cancer Treatment Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 67: South America, Nanotechnology In Cancer Treatment Market, Segmentation By Nanotechnology Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 68: South America, Nanotechnology In Cancer Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 69: South America, Nanotechnology In Cancer Treatment Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 70: Brazil, Nanotechnology In Cancer Treatment Market, Segmentation By Nanotechnology Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 71: Brazil, Nanotechnology In Cancer Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 72: Brazil, Nanotechnology In Cancer Treatment Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 73: Middle East, Nanotechnology In Cancer Treatment Market, Segmentation By Nanotechnology Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 74: Middle East, Nanotechnology In Cancer Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 75: Middle East, Nanotechnology In Cancer Treatment Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 76: Africa, Nanotechnology In Cancer Treatment Market, Segmentation By Nanotechnology Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 77: Africa, Nanotechnology In Cancer Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 78: Africa, Nanotechnology In Cancer Treatment Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 79: Pfizer Inc. Financial Performance
  • Figure 80: AstraZeneca PLC Financial Performance
  • Figure 81: Novartis AG Financial Performance
  • Figure 82: Amgen Inc. Financial Performance
  • Figure 83: GE Healthcare Technologies Inc. Financial Performance

Frequently Asked Questions

Nanotechnology in cancer treatment involves utilizing nanoscale materials and tools to enhance cancer diagnosis, monitoring, and therapy. It allows for precise drug delivery to cancer cells, reducing harm to surrounding healthy tissues. This approach aims to boost treatment effectiveness, lower side effects, and support personalized medicine strategies. For further insights on this market, request a sample here

The market major growth driver - Rising Demand For Targeted Therapies Drives Growth In Nanotechnology-Based Cancer Treatment Due To Their Precision In Attacking Cancer Cells. For further insights on this market, request a sample here

The nanotechnology in the cancer treatment market size has grown rapidly in recent years. It will grow from $137.90 billion in 2024 to $159.09 billion in 2025 at a compound annual growth rate (CAGR) of 15.4%. The growth in the historic period can be attributed to the early rising prevalence of cancer globally, increasing awareness of early cancer detection, increasing research and development investments in nanomedicine, rising adoption of minimally invasive treatments, and increasing government funding for oncology nanotech research. The nanotechnology in the cancer treatment market size is expected to see rapid growth in the next few years. It will grow to $278.07 billion in 2029 at a compound annual growth rate (CAGR) of 15.0%. The growth in the forecast period can be attributed to rising demand for targeted cancer therapies, increasing integration of nanotechnology in drug delivery systems, growing focus on personalized oncology treatment, increasing clinical trials for nano-enabled cancer drugs, and rising adoption of nanotheranostics in cancer care. Major trends in the forecast period include advancement in nanoparticle drug delivery platforms, innovation in cancer-specific nanocarriers, integration of AI with nanotechnology for precision oncology, development of multifunctional nanodevices for diagnosis and therapy, and expansion of nanotheranostics in personalized medicine. For further insights on this market, request a sample here

The nanotechnology in cancer treatment market covered in this report is segmented
1) By Nanotechnology Type: Liposomes, Dendrimers, Nanoparticles
2) By Treatment Type: Chemotherapy, Immunotherapy, Targeted Therapy, Combined Therapy Approaches, Surgery Assistance
3) By Cancer Type: Breast Cancer, Lung Cancer, Prostate Cancer, Colorectal Cancer, Blood Cancer, Other Cancer Types
4) By Application: Targeted Drug Delivery, Photothermal Therapy, Radiation Therapy Enhancement, Diagnostics And Imaging, Gene Delivery Systems
5) By End-User: Hospitals, Research Institutions, Diagnostics Laboratories, Pharmaceutical Companies, Contract Research Organizations (CROs) Subsegments:
1) By Liposomes: Conventional Liposomes, Stealth Liposomes, Cationic Liposomes, Immunoliposomes
2) By Dendrimers: Polyamidoamine Dendrimers, Polypropyleneimine Dendrimers, Peptide-Based Dendrimers, Carbosilane Dendrimers
3) By Nanoparticles: Gold Nanoparticles, Magnetic Nanoparticles, Polymeric Nanoparticles, Quantum Dots, Lipid Nanoparticles For further insights on this market,
request a sample here

North America was the largest region in the nanotechnology in cancer treatment market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the nanotechnology in cancer treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. For further insights on this market, request a sample here.

Major companies operating in the nanotechnology in cancer treatment market are Pfizer Inc., AstraZeneca PLC, Novartis AG, Amgen Inc., GE Healthcare Technologies Inc., Eisai Co. Ltd., Jazz Pharmaceuticals plc, Arrowhead Pharmaceuticals Inc., Nanobiotix S.A., EnGeneIC Ltd., Nanospectra Biosciences Inc., Sona Nanotech Inc., CritiTech Inc., Immix Biopharma Inc., DNA Nanobots LLC, Nanovery Limited, CytImmune Sciences Inc., NanOlogy LLC, NanoApps Medical Inc., ARIZ Precision Medicine. . For further insights on this market, request a sample here.

Major trends in this market include Breakthrough In Nanotechnology-Enabled Immunotherapy For Precision Cancer Treatment. For further insights on this market, request a sample here.

Customer representative image Book your 30 minutes free consultation with our research experts
Back to top WhatsApp icon